Compound Evidence File
#EC-2026-0519
SR9009
Filed under Oral Tablets. The bureau holds 136 laboratory returns for this compound from 54 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
54 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 2 May 2026 | 12 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 10.0 | 10.0 | 4 May 2026 | 16 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Mar 2026 | 28 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Nov 2025 | 8 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Dec 2025 | 27 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 12 May 2026 | 19 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Mar 2026 | 22 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Apr 2026 | 18 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Mar 2026 | 3 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 4 Mar 2026 | 9 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Apr 2026 | 7 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Aug 2026 | 15 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 24 Feb 2026 | 9 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 6 Dec 2025 | 9 Feb 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Jan 2026 | 9 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 9.9 | 15 Jan 2026 | 26 Apr 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 24 Dec 2025 | 14 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Feb 2026 | 27 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Dec 2025 | 20 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 4 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Jan 2026 | 28 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 9.3 | 8.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 9.2 | 7.7 | 10.0 | 25 May 2026 | 25 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 8.8 | 8.8 | 8.8 | 14 Jan 2025 | 14 Jan 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.5 | 7.2 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.2 | 6.2 | 9.9 | 23 May 2026 | 23 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 8.0 | 6.5 | 9.1 | 11 Jun 2025 | 21 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.0 | 8.0 | 8.0 | 24 Apr 2025 | 24 Apr 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 7.9 | 5.8 | 10.0 | 24 Apr 2025 | 21 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 7.9 | 7.9 | 7.9 | 16 Mar 2025 | 16 Mar 2025 |
| Mai PeptideCASE #VI-2026-0769 | X | 2 | 7.8 | 5.7 | 10.0 | 2 Apr 2025 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 7.7 | 7.1 | 8.4 | 23 May 2026 | 23 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 7.7 | 7.7 | 7.7 | 2 Apr 2025 | 2 Apr 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 7.5 | 5.5 | 9.6 | 21 May 2025 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 | 13 Jun 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 7.3 | 7.3 | 7.3 | 3 Jul 2025 | 3 Jul 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 | 14 Jan 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 6.6 | 6.6 | 6.6 | 3 Jun 2025 | 3 Jun 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 | 14 Jan 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 6.3 | 6.0 | 6.7 | 8 Jul 2025 | 20 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 | 28 Mar 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 | 13 Jun 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 6.0 | 6.0 | 6.0 | 13 Feb 2025 | 13 Feb 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 5.7 | 5.7 | 5.7 | 2 Apr 2025 | 2 Apr 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 | 7 May 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 | 11 Jun 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 4.4 | 4.2 | 4.6 | 27 Feb 2025 | 20 May 2026 |
| Peptides For SaleCASE #VI-2026-0614 | X | 2 | 4.2 | 3.7 | 4.8 | 6 May 2025 | 25 May 2026 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 4.0 | 4.0 | 4.0 | 20 Jun 2025 | 20 Jun 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.7 | 3.7 | 3.7 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 2 | 2.5 | 2.1 | 2.9 | 27 Feb 2025 | 17 May 2026 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 1.2 | 1.2 | 1.2 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for SR9009 alone.